Featured in Alopecia
Weekly Featured
Mission Possible? Managing Scarring Alopecia
Discover this week's featured video and expert opinion
Latest Alopecia Videos
Featured CME on Alopecia
0.5 Credit
Click to save this course
Alopecia
CME
'Hair’ For The Long Haul: Alopecia Areata Cases and Considerations
Release Date
December 2, 2025
0.25 Credit
Click to save this course
Alopecia
CME
HowTo’ Approach Long-Term Care in Alopecia Areata: Practical Considerations
Release Date
September 18, 2025
0.25 Credit
Click to save this course
Alopecia
CME
PosterToPractice: Practical Pearls From Alopecia Areata Abstracts
Release Date
March 21, 2025
0.25 Credit
Click to save this course
Alopecia
CME
CMEswiper: Swipe to the Future of Alopecia Areata
Tips and Tricks for Using Oral JAK Inhibitors: An Online Activity
Release Date
February 24, 2025
Alopecia Episodes to Explore
Episode 6
Watch and Listen: How You Can Integrate Regenerative Procedures to Treat Alopecia
In this episode of Tea with Dr. D, host James Q. Del Rosso, DO, is joined by Gary Goldenberg, MD, for an...
Episode 127
Alopecia Areata Update: There's A New Kid in Town
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, is joined by Natasha Mesinkovska, MD, associate professor of...
Alopecia News & Research
Risk for Nonscarring Hair Loss Increased in Association With GLP-1 Receptor Agonist Use
GLP-1 RAs linked to increased risk for androgenetic alopecia, nonscarring hair loss, telogen effluvium at six months
By Elana Gotkine (HealthDay News) | | March 05, 2026
Switching Between JAK Inhibitors Viable for Severe Alopecia Areata
Patients who responded to their first Janus kinase inhibitor were more likely to respond to a second one
By Dermsquared Editorial Team | | March 05, 2026
Clinically Meaningful Hair Regrowth Seen With Ivarmacitinib for Severe Alopecia Areata
Severity of Alopecia Tool score ≤20 at week 24 achieved by 34.9, 40.6, and 9.0 percent of patients receiving 4 mg, 8 mg ivarmacitinib,...
By Dermsquared Editorial Team | | January 21, 2026